Payment overview · 2025
General Payments
$274.25
6 reported records · 4 companies
Healthcare provider profile · identity verified
Michael Thomas Cox, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · LIVINGSTON, TN · NPI 1356305197
Verified facts
What the public records show
CMS Open Payments records show Michael Thomas Cox, M.D. received $274.25 in general payments during 2025 across 6 reported records.
AtriCure, Inc. accounted for 64.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Xifaxan.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 160 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NEXIUM as an associated drug or biological on 464 records involving 299 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Nexium by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Symbicort by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 139 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Rybelsus by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIFAXAN as an associated drug or biological on 101901 records involving 33018 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Xifaxan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $176.25 | 64.3% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $46.99 | 17.1% | 3 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $28.01 | 10.2% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $23.00 | 8.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $274.25 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Normalized: epi sense guided coagulation system with visitrax |
Device | AtriCure, Inc. | $176.25 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $46.99 | 3 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| XIFAXAN xifaxan |
2025 | Xifaxan | 2024 | 27 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
160 | 17 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | NEXIUM open payments reported associated product |
CMS Open Payments — General Payments 464 supporting records · 299 recipient NPIs · example record 1206134180 |
Nexium · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
139 | 34 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | XIFAXAN open payments reported associated product |
CMS Open Payments — General Payments 101901 supporting records · 33018 recipient NPIs · example record 1231775337 |
Xifaxan · 2024 Exact normalized brand match · 1 Part D row |
27 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 2439 | 233 |
| Atorvastatin Calcium | Atorvastatin Calcium | 2270 | 341 |
| Lisinopril | Lisinopril | 1528 | 212 |
| Furosemide | Furosemide | 1476 | 198 |
| Eliquis | Apixaban | 1442 | 101 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1341 | 152 |
| Potassium Chloride | Potassium Chloride | 1175 | 148 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1055 | 201 |
| Trazodone Hcl | Trazodone Hcl | 972 | 110 |
| Amlodipine Besylate | Amlodipine Besylate | 953 | 158 |
| Mirtazapine | Mirtazapine | 883 | 91 |
| Metformin Hcl | Metformin Hcl | 882 | 144 |
| Tamsulosin Hcl | Tamsulosin Hcl | 785 | 109 |
| Gabapentin | Gabapentin | 772 | 131 |
| Spironolactone | Spironolactone | 733 | 96 |
| Sertraline Hcl | Sertraline Hcl | 672 | 80 |
| Carvedilol | Carvedilol | 659 | 75 |
| Famotidine | Famotidine | 654 | 102 |
| Omeprazole | Omeprazole | 641 | 141 |
| Metoprolol Succinate | Metoprolol Succinate | 615 | 117 |
| Clopidogrel | Clopidogrel Bisulfate | 609 | 79 |
| Losartan Potassium | Losartan Potassium | 581 | 100 |
| Buspirone Hcl | Buspirone Hcl | 545 | 59 |
| Quetiapine Fumarate | Quetiapine Fumarate | 494 | 48 |
| Escitalopram Oxalate | Escitalopram Oxalate | 493 | 62 |
| Citalopram Hbr | Citalopram Hydrobromide | 486 | 62 |
| Donepezil Hcl | Donepezil Hcl | 484 | 70 |
| Divalproex Sodium | Divalproex Sodium | 472 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 463 | 74 |
| Glipizide | Glipizide | 431 | 81 |
| Jardiance | Empagliflozin | 409 | 43 |
| Levetiracetam | Levetiracetam | 392 | 32 |
| Meloxicam | Meloxicam | 328 | 75 |
| Allopurinol | Allopurinol | 326 | 52 |
| Simvastatin | Simvastatin | 315 | 74 |
| Fluoxetine Hcl | Fluoxetine Hcl | 299 | 44 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 297 | 68 |
| Pravastatin Sodium | Pravastatin Sodium | 271 | 40 |
| Atenolol | Atenolol | 265 | 60 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 256 | 50 |
| Prednisone | Prednisone | 250 | 90 |
| Ropinirole Hcl | Ropinirole Hcl | 245 | 39 |
| Memantine Hcl | Memantine Hcl | 241 | 27 |
| Olanzapine | Olanzapine | 230 | 19 |
| Baclofen | Baclofen | 229 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 229 | 71 |
| Xarelto | Rivaroxaban | 226 | 22 |
| Warfarin Sodium | Warfarin Sodium | 219 | 36 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 214 | 42 |
| Hydralazine Hcl | Hydralazine Hcl | 207 | 29 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 202 | 30 |
| Tizanidine Hcl | Tizanidine Hcl | 196 | 49 |
| Tramadol Hcl | Tramadol Hcl | 194 | 52 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 186 | 61 |
| Midodrine Hcl | Midodrine Hcl | 183 | 15 |
| Lamotrigine | Lamotrigine | 180 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 177 | 51 |
| Clonazepam | Clonazepam | 176 | 21 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 172 | 52 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 172 | 26 |
| Pregabalin | Pregabalin | 171 | 34 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 169 | 43 |
| Sucralfate | Sucralfate | 166 | 21 |
| Farxiga | Dapagliflozin Propanediol | 160 | 17 |
| Metoclopramide Hcl | Metoclopramide Hcl | 160 | 25 |
| Alendronate Sodium | Alendronate Sodium | 157 | 40 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 156 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 155 | 20 |
| Ibuprofen | Ibuprofen | 154 | 34 |
| Ondansetron Hcl | Ondansetron Hcl | 153 | 73 |
| Methocarbamol | Methocarbamol | 147 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 146 | 43 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 145 | 28 |
| Oxycodone Hcl | Oxycodone Hcl | 143 | 31 |
| Risperidone | Risperidone | 143 | 15 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 142 | 32 |
| Ozempic | Semaglutide | 139 | 34 |
| Celecoxib | Celecoxib | 138 | 42 |
| Nystatin | Nystatin | 138 | 70 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 136 | 26 |
| Alprazolam | Alprazolam | 135 | 23 |
| Montelukast Sodium | Montelukast Sodium | 134 | 39 |
| Glimepiride | Glimepiride | 132 | 27 |
| Lorazepam | Lorazepam | 130 | 31 |
| Myrbetriq | Mirabegron | 122 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 121 | 41 |
| Promethazine Hcl | Promethazine Hcl | 120 | 43 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 117 | 24 |
| Januvia | Sitagliptin Phosphate | 110 | 12 |
| Lovastatin | Lovastatin | 110 | 31 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 107 | 34 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 104 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 102 | 20 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 101 | 77 |
| Finasteride | Finasteride | 98 | 17 |
| Bupropion Hcl | Bupropion Hcl | 96 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 96 | 24 |
| Diltiazem Hcl | Diltiazem Hcl | 95 | 14 |
| Amiodarone Hcl | Amiodarone Hcl | 93 | 21 |
| Cefdinir | Cefdinir | 93 | 78 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 92 | 40 |
| Nifedipine Er | Nifedipine | 91 | 16 |
| Estradiol | Estradiol | 89 | 21 |
| Ramipril | Ramipril | 88 | 25 |
| Meclizine Hcl | Meclizine Hcl | 86 | 34 |
| Gemfibrozil | Gemfibrozil | 85 | 14 |
| Enalapril Maleate | Enalapril Maleate | 84 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 82 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 77 | 21 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 77 | 64 |
| Fluconazole | Fluconazole | 76 | 47 |
| Doxycycline Hyclate | Doxycycline Hyclate | 75 | 49 |
| Azithromycin | Azithromycin | 72 | 62 |
| Divalproex Sodium Er | Divalproex Sodium | 71 | suppressed |
| Lactulose | Lactulose | 71 | 24 |
| Diltiazem 24hr Er | Diltiazem Hcl | 70 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 69 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 69 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 68 | 15 |
| Methylprednisolone | Methylprednisolone | 68 | 60 |
| Calcium Acetate | Calcium Acetate | 67 | suppressed |
| Latanoprost | Latanoprost | 67 | 12 |
| Bupropion Xl | Bupropion Hcl | 65 | 11 |
| Carbamazepine | Carbamazepine | 65 | suppressed |
| Ranolazine Er | Ranolazine | 65 | suppressed |
| Linzess | Linaclotide | 64 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 62 | 23 |
| Primidone | Primidone | 62 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 61 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 59 | suppressed |
| Ondansetron Odt | Ondansetron | 59 | 41 |
| Cephalexin | Cephalexin | 57 | 34 |
| Liothyronine Sodium | Liothyronine Sodium | 57 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 57 | 15 |
| Haloperidol | Haloperidol | 56 | suppressed |
| Levofloxacin | Levofloxacin | 56 | 41 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 56 | suppressed |
| Verapamil Sr | Verapamil Hcl | 55 | suppressed |
| Naproxen | Naproxen | 54 | 15 |
| Sulfasalazine | Sulfasalazine | 54 | suppressed |
| Synthroid | Levothyroxine Sodium | 54 | 14 |
| Morphine Sulfate Er | Morphine Sulfate | 53 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 53 | 13 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 51 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 51 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 49 | suppressed |
| Entresto | Sacubitril/Valsartan | 48 | suppressed |
| Chlorthalidone | Chlorthalidone | 47 | 12 |
| Novolog Flexpen | Insulin Aspart | 47 | 15 |
| Topiramate | Topiramate | 47 | suppressed |
| Acyclovir | Acyclovir | 46 | 18 |
| Bumetanide | Bumetanide | 46 | 15 |
| Breo Ellipta | Fluticasone/Vilanterol | 45 | 11 |
| Clonidine Hcl | Clonidine Hcl | 44 | 23 |
| Nitroglycerin | Nitroglycerin | 44 | 29 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 43 | suppressed |
| Torsemide | Torsemide | 43 | 12 |
| Dexlansoprazole Dr | Dexlansoprazole | 41 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 41 | 17 |
| Gemtesa | Vibegron | 41 | suppressed |
| Nystop | Nystatin | 41 | 24 |
| Phenobarbital | Phenobarbital | 41 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 40 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 40 | 30 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 40 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 39 | suppressed |
| Budesonide | Budesonide | 39 | suppressed |
| Diazepam | Diazepam | 39 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 38 | 12 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 38 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 38 | 18 |
| Veltassa | Patiromer Calcium Sorbitex | 38 | suppressed |
| Mupirocin | Mupirocin | 37 | 28 |
| Ezetimibe | Ezetimibe | 36 | 14 |
| Hydrocortisone | Hydrocortisone | 36 | 19 |
| Doxepin Hcl | Doxepin Hcl | 35 | suppressed |
| Febuxostat | Febuxostat | 35 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 35 | 15 |
| Leflunomide | Leflunomide | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 34 | 15 |
| Venlafaxine Hcl | Venlafaxine Hcl | 34 | suppressed |
| Cholestyramine Light | Cholestyramine | 33 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 13 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 32 | suppressed |
| Digoxin | Digoxin | 32 | suppressed |
| Glipizide Er | Glipizide | 32 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 32 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 32 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 31 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 25 |
| Dexamethasone | Dexamethasone | 30 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Insulin Lispro | Insulin Lispro | 29 | suppressed |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Lidocaine | Lidocaine | 29 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 28 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 28 | suppressed |
| Mounjaro | Tirzepatide | 28 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 28 | suppressed |
| Amantadine | Amantadine Hcl | 27 | suppressed |
| Calcitriol | Calcitriol | 27 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 27 | suppressed |
| Ertapenem | Ertapenem Sodium | 27 | 21 |
| Xifaxan | Rifaximin | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 26 | suppressed |
| Acetazolamide | Acetazolamide | 25 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 25 | suppressed |
| Klor-Con 10 | Potassium Chloride | 25 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 25 | 14 |
| Novolog | Insulin Aspart | 25 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 25 | suppressed |
| Loperamide | Loperamide Hcl | 24 | suppressed |
| Sotalol | Sotalol Hcl | 24 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 24 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 23 | 17 |
| Ipratropium Bromide | Ipratropium Bromide | 23 | suppressed |
| Amoxicillin | Amoxicillin | 22 | 14 |
| Dantrolene Sodium | Dantrolene Sodium | 22 | suppressed |
| Humalog | Insulin Lispro | 22 | suppressed |
| Kerendia | Finerenone | 21 | suppressed |
| Levemir Flexpen | Insulin Detemir | 21 | suppressed |
| Renvela | Sevelamer Carbonate | 21 | suppressed |
| Folic Acid | Folic Acid | 20 | suppressed |
| Lubiprostone | Lubiprostone | 20 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 20 | suppressed |
| Premarin | Estrogens, Conjugated | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Fentanyl | Fentanyl | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 19 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 19 | suppressed |
| Timolol Maleate | Timolol Maleate | 19 | suppressed |
| Acetylcysteine | Acetylcysteine | 18 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 18 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 18 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 18 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 18 | 11 |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 17 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 17 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 17 | 14 |
| Semglee (Yfgn) | Insulin Glargine-Yfgn | 17 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 17 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Cilostazol | Cilostazol | 16 | suppressed |
| Nexium | Esomeprazole Magnesium | 16 | suppressed |
| Restasis | Cyclosporine | 16 | suppressed |
| Zonisamide | Zonisamide | 16 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 15 | suppressed |
| Humulin R | Insulin Regular, Human | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 14 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 14 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 14 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | 11 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 13 | suppressed |
| Nyamyc | Nystatin | 13 | 12 |
| Osphena | Ospemifene | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Risperidone Odt | Risperidone | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 13 | suppressed |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Dalfampridine Er | Dalfampridine | 12 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 12 | suppressed |
| Glucagon Emergency Kit | Glucagon | 12 | suppressed |
| Humira(Cf) Pen | Adalimumab | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Valproic Acid | Valproic Acid | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 11 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 11 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 11 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Silodosin | Silodosin | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $274.25 · 6 records | AtriCure, Inc. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Wegovy, XIFAXAN | 7 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Xifaxan play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error